Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04231097 · ClinicalTrials.gov registry record · NA
MBCT Delivered Via Group Videoconferencing for ACS Syndrome Patients With Depressive Symptoms
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT04231097: Completed NA study, sponsored by Massachusetts General Hospital.
NCT04231097 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04231097, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
Brief Summary: The aim of this study is to explore the initial feasibility and acceptability of (a) Mindfulness-Based Cognitive Therapy (MBCT) adapted for ACS patients; (b) the group videoconferencing delivery medium; and (c) dried blood spot research procedures, to inform refinements for a subsequent pilot RCT.
Primary Outcome
Feasibility outcomes for recruitment will include: \>70% of patients reached consent to screening
Interventions
- OTHER MBCT intervention for ACS patients
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2020-04-24 |
| Est. Completion | 2021-03-01 |
| Phase | NA |
What the finished NCT04231097 record still lists
NCT04231097 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which MBCT intervention for ACS patients is the first listed.
NCT04231097 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04231097 about?
NCT04231097 is a clinical study titled "MBCT Delivered Via Group Videoconferencing for ACS Syndrome Patients With Depressive Symptoms". Brief Summary: The aim of this study is to explore the initial feasibility and acceptability of (a) Mindfulness-Based Cognitive Therapy (MBCT) adapted for ACS patients; (b) the group videoconferencing delivery medium; and (c) dried blood spot research procedures, to inform refinements for a subseque...
What is the current status of trial NCT04231097?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2020-04-24. Estimated completion is 2021-03-01.
What interventions are being tested in trial NCT04231097?
The interventions under investigation include: MBCT intervention for ACS patients (OTHER).
Who is sponsoring clinical trial NCT04231097?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04231097's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI